Directors’ Dealings | 14 May 2024 11:08

APONTIS PHARMA AG: be executive GmbH, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
14.05.2024 / 11:07 CET/CEST
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Name and legal form: be executive GmbH

2. Reason for the notification

a) Position / status

Person closely associated with:
Title:
First name:	Bruno
Last name(s):	Wohlschlegel
Position:	Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

APONTIS PHARMA AG

b) LEI

894500ETO1J6MR8PDF91

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A3CMGM5

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s)	Volume(s)
8.88 EUR	8,880.00 EUR

d) Aggregated information

Price	Aggregated volume
8.8800 EUR	8,880.0000 EUR

e) Date of the transaction

2024-05-13; UTC+2

f) Place of the transaction

Name:	Tradegate
MIC:	TGAT

14.05.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language:	English
Company:	APONTIS PHARMA AG
	Alfred-Nobel-Str. 10
	40789 Monheim
	Germany
Internet:	https://apontis-pharma.de/

End of News EQS News Service